Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C.. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussion could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Development of Immune Monitoring Reagents & MHC Typing Technologies for Non-Human Primates.
Date: May 24, 2004.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.
Contact Person: Quirijn Vos, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-496-2550, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS.)Start Signature
Dated: April 29, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-10323 Filed 5-5-04; 8:45 am]
BILLING CODE 4140-01-M